Officers in Dallas have raided three licensed distribution warehouses in the Harry Hines district: Monster, Frontline Wholesale, and Cannafy Distribution. All three companies distribute fully federally compliant hemp-derived products, sold nationwide and verified by Certificates of Analysis (COAs) from certified laboratories.

Each product includes a QR code that links directly to its Certificate of Analysis (COA) — a legally binding document, signed by a DEA-registered, ISO-accredited lab director, confirming that the product meets the legal requirement of less than 0.3% delta-9 THC. These tests follow validated scientific methods.

“Monster Distribution has complied with the law in every way”, said David Sergi, attorney for Monster. “They relied in good faith on licensed, accredited labs to verify that the products meet all legal standards. This raid was not based on facts. It was based on political theater. And when law enforcement acts outside its authority to deprive businesses and individuals of their rights and property, it raises serious legal concerns.”
Continue reading

Massachusetts has generated over $803 million in legal marijuana sales so far in 2025.

Of these sales, $737.7 million came from adult-use purchases and another $66 million from medical marijuana sales, according to data from the Cannabis Control Commission. The updated figures run through June 15.

Since retail marijuana sales began in 2018, Massachusetts has now sold a total of $9.39 billion worth of cannabis products—$7.94 billion in adult-use and $1.45 billion in medical sales.
Continue reading

The North Carolina Senate is moving quickly on legislation that would impose new restrictions on hemp-derived THC products, including a ban on the sale of certain drinks and edibles to those under 21.

Hemp field.

The Senate Standing Committee on Health Care is scheduled to vote on the proposal Tuesday morning, with lawmakers aiming to pass the measure before adjourning later this month.

The legislation would replace House Bill 328, a more modest bill approved earlier in the session that banned Delta-8 and Delta-9 THC on school grounds. Senate Republicans say the update is necessary to rein in an increasingly unregulated market.
Continue reading

With just two weeks left before Pennsylvania’s new fiscal year begins on July 1, the push to legalize marijuana for adult use is emerging as a central issue in ongoing budget negotiations.

Governor Josh Shapiro’s $51.5 billion budget plan depends in part on new revenue from legal cannabis sales—part of a broader Democratic effort to make Pennsylvania the 25th state to legalize recreational marijuana. The House passed a legalization bill last month that would allow those 21 and older to possess and purchase marijuana, but Senate Republican leaders have yet to embrace the proposal.

Shapiro’s budget counts on $1.2 billion in new tax revenue from a combination of adult-use marijuana sales, expanded application of the corporate net income tax, and regulation of skill games. Without marijuana legalization, a significant portion of that projected revenue disappears, leaving a larger hole in the state’s finances.
Continue reading

The New York Senate has approved a bill that would give marijuana distributors more time to submit their quarterly tax returns, passing the measure 38 to 21 last week.

The proposal, Senate Bill 8091 and Assembly Bill 5496, is sponsored by Senator Jeremy Cooney (D) and Assemblymember Donna Lupardo (D). The legislation would amend Section 495 of the state’s tax law to extend the filing deadline for cannabis distributors.

Under current law, returns must be filed by the 20th day of the month following the end of each quarter. SB 8091 would change that to the 15th day after the quarter ends, giving distributors an additional 25 to 30 days to file. The affected quarterly periods end on the last day of February, May, August, and November.
Continue reading

Alabama State Senator Tim Melson, a Republican and practicing anesthesiologist, is urging federal officials to reschedule marijuana, calling the move “urgent” in a new op-ed published by the Alabama Daily News.

Melson, who sponsored Alabama’s medical marijuana law—the 2021 Compassion Act—used the piece to advocate for reclassifying marijuana from Schedule I to Schedule III under the federal Controlled Substances Act. He argues that current federal restrictions ignore scientific evidence, create unnecessary barriers to research, and complicate patient access.

“As a physician and as a legislator, my duty is to safeguard the well-being of the people I serve,” Melson wrote, noting that his clinical experience has shown how cannabis can provide relief where traditional treatments fall short. “That is why… I proudly sponsored Alabama’s Compassion Act.”

Continue reading

Arkansas now has over 110,000 registered medical marijuana patients, according to data provided by the state’s Department of Health.

The figure reflects steady growth in the program, with nearly 10,000 new patients added since the start of 2025. In total, there is now 110,554 medical cannabis patients in Arkansas.

Medical marijuana was legalized in Arkansas through a voter-approved initiative in November 2016, receiving 53% support. The law allows qualifying patients to legally obtain and use marijuana and marijuana products for any of 17 approved conditions, including cancer, PTSD, seizures, and chronic pain.
Continue reading